Close Menu

NEW YORK — Australian biotech firm Microba said today that it has partnered with Macrogen subsidiary Psomagen to introduce a microbiome analysis test in the US.

Microba recently launched a direct-to-consumer service in Australia called Insight, which uses shotgun metagenomics to analyze customers' gut microbiomes and generate a personalized report. Under the terms of the deal, Psomagen will introduce a microbiome test based on Microba's technologies in the US before the end of the year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.